Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Detecting gene-gene interactions in prostate disease in African American men.

Reams RR, Kalari KR, Wang H, Odedina FT, Soliman KF, Yates C.

Infect Agent Cancer. 2011 Sep 23;6 Suppl 2:S1. doi: 10.1186/1750-9378-6-S2-S1.

2.

Immunohistological analysis of ABCD3 expression in Caucasian and African American prostate tumors.

Reams RR, Jones-Triche J, Chan OT, Hernandez BY, Soliman KF, Yates C.

Biomed Res Int. 2015;2015:132981. doi: 10.1155/2015/132981.

3.

MiRNA 26a expression in a novel panel of African American prostate cancer cell lines.

Theodore SC, Rhim JS, Turner T, Yates C.

Ethn Dis. 2010 Winter;20(1 Suppl 1):S1-96-100.

4.

Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.

Bensen JT, Xu Z, Smith GJ, Mohler JL, Fontham ET, Taylor JA.

Prostate. 2013 Jan;73(1):11-22. doi: 10.1002/pros.22532.

5.

Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: a pilot project study.

Reams RR, Agrawal D, Davis MB, Yoder S, Odedina FT, Kumar N, Higginbotham JM, Akinremi T, Suther S, Soliman KF.

Infect Agent Cancer. 2009 Feb 10;4 Suppl 1:S3. doi: 10.1186/1750-9378-4-S1-S3.

6.

Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians.

Shiina M, Hashimoto Y, Kato T, Yamamura S, Tanaka Y, Majid S, Saini S, Varahram S, Kulkarni P, Dasgupta P, Mitsui Y, Sumida M, Tabatabai L, Deng G, Kumar D, Dahiya R.

Oncotarget. 2017 Jan 31;8(5):8356-8368. doi: 10.18632/oncotarget.14198.

7.

Robust gene network analysis reveals alteration of the STAT5a network as a hallmark of prostate cancer.

Reddy A, Huang CC, Liu H, Delisi C, Nevalainen MT, Szalma S, Bhanot G.

Genome Inform. 2010;24:139-53.

PMID:
22081596
8.
9.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.

Prostate. 2003 Mar 1;54(4):249-57.

PMID:
12539223
10.

Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men.

Timofeeva OA, Zhang X, Ressom HW, Varghese RS, Kallakury BV, Wang K, Ji Y, Cheema A, Jung M, Brown ML, Rhim JS, Dritschilo A.

Int J Oncol. 2009 Oct;35(4):751-60.

11.

High circulating estrogens and selective expression of ERĪ² in prostate tumors of Americans: implications for racial disparity of prostate cancer.

Abd Elmageed ZY, Moroz K, Srivastav SK, Fang Z, Crawford BE, Moparty K, Thomas R, Abdel-Mageed AB.

Carcinogenesis. 2013 Sep;34(9):2017-23. doi: 10.1093/carcin/bgt156.

12.

Androgen receptor mutations and polymorphisms in African American prostate cancer.

Koochekpour S, Buckles E, Shourideh M, Hu S, Chandra D, Zabaleta J, Attwood K.

Int J Biol Sci. 2014 Jun 5;10(6):643-51. doi: 10.7150/ijbs.8974.

13.

Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.

Kwabi-Addo B, Wang S, Chung W, Jelinek J, Patierno SR, Wang BD, Andrawis R, Lee NH, Apprey V, Issa JP, Ittmann M.

Clin Cancer Res. 2010 Jul 15;16(14):3539-47. doi: 10.1158/1078-0432.CCR-09-3342.

14.

Copy number and gene expression differences between African American and Caucasian American prostate cancer.

Rose AE, Satagopan JM, Oddoux C, Zhou Q, Xu R, Olshen AB, Yu JZ, Dash A, Jean-Gilles J, Reuter V, Gerald WL, Lee P, Osman I.

J Transl Med. 2010 Jul 22;8:70. doi: 10.1186/1479-5876-8-70.

15.

Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer.

Yang Y, Jia D, Kim H, Abd Elmageed ZY, Datta A, Davis R, Srivastav S, Moroz K, Crawford BE, Moparty K, Thomas R, Hudson RS, Ambs S, Abdel-Mageed AB.

Clin Cancer Res. 2016 Apr 1;22(7):1744-56. doi: 10.1158/1078-0432.CCR-15-1606.

PMID:
26553749
16.

GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP).

Xu Z, Bensen JT, Smith GJ, Mohler JL, Taylor JA.

Prostate. 2011 Jun 1;71(8):881-91. doi: 10.1002/pros.21304.

17.

Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort.

Sucheston LE, Bensen JT, Xu Z, Singh PK, Preus L, Mohler JL, Su LJ, Fontham ET, Ruiz B, Smith GJ, Taylor JA.

PLoS One. 2012;7(3):e30950. doi: 10.1371/journal.pone.0030950.

18.

Tumor immunobiological differences in prostate cancer between African-American and European-American men.

Wallace TA, Prueitt RL, Yi M, Howe TM, Gillespie JW, Yfantis HG, Stephens RM, Caporaso NE, Loffredo CA, Ambs S.

Cancer Res. 2008 Feb 1;68(3):927-36. doi: 10.1158/0008-5472.CAN-07-2608.

19.

Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.

Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV, Ureda JR, Hebert JR.

J S C Med Assoc. 2006 Aug;102(7):241-9. Review.

PMID:
17319238
20.

Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.

Ritch CR, Morrison BF, Hruby G, Coard KC, Mayhew R, Aiken W, Benson MC, McKiernan JM.

BJU Int. 2013 Apr;111(4 Pt B):E186-90. doi: 10.1111/j.1464-410X.2012.11540.x.

Supplemental Content

Support Center